241
Views
37
CrossRef citations to date
0
Altmetric
Research Article

Colon-specific delivery of mesalazine chitosan microspheres

, &
Pages 329-339 | Received 01 Jun 2005, Accepted 10 Nov 2005, Published online: 08 Oct 2008

References

  • Agnihotri AS, Aminabhavi TM. Formulation and evaluation of novel tableted chitosan microparticles for the controlled release of clozapine. Journal of Microencapsulation 2004; 21: 709–718
  • Arnaud P, Boué C, Chaumeil JC. Cellulose acetate butyrate microparticles for controlled release of carbamazepine. Journal of Microencapsulation 1996; 13: 407–417
  • Berthold A, Cremer K, Kreuter J. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. Journal of Controlled Release 1996; 39: 17–25
  • Bussemer T, Otto I, Bodmeier R. Pulsatile drug-delivery systems. Drug Carrier Systems 2001; 18: 433–458
  • Chae SY, Jang MK, Nah JW. Influence of molecular weight on oral absorption of water soluble chitosans. Journal of Controlled Release 2005; 102: 383–394
  • Costa P, Manuel J, Lobo S. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences 2001; 13: 123–133
  • Deasy PB. Microencapsulation and related drug process. Marcel Dekker, New York 1984; 108
  • Genta I, Perugini P, Conti B, Pavanetto F. A multiple emulsion method to entrap a lipophilic compound into chitosan microspheres. International Journal of Pharmaceutics 1997; 152: 237–246
  • Genta I, Perugini P, Pavanetto F. Different molecular weight chitosan microspheres: Influence on drug loading and drug release. Drug Development and Industrial Pharmacy 1998; 24: 779–784
  • Gohel MC, Panchal MK. Novel use of similarity factors f2 and Sd for development of diltiazem HCl modified-Release tablets using a 32 factorial design. Drug Development and Industrial Pharmacy 2002; 28: 77–87
  • Gorbach SL. Intestinal flora. Gastroenterology 1971; 60: 1110–1129
  • He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. International Journal of Pharmaceutics 1998; 166: 68–75
  • He P, Davis SS, Illum L. Chitosan microspheres prepared by spray drying. International Journal of Pharmaceutics 1999a; 187: 53–65
  • He P, Davis SS, Illum L. Sustained release chitosan microspheres prepared by spray drying methods. Journal of Microencapsulation 1999b; 16: 343–355
  • İkinci G, Şenel S, Akıncıbay H, Kaş S, Erciş S, Wilson CG, Hıncal AA. Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. International Journal of Pharmaceutics 2002; 235: 121–127
  • Illum L, Farraj NF, Davis SS. Chitosan as a novel nasal delivery system for peptide drugs. Pharmaceutical Research 1994; 11: 1186–1189
  • Kas HS. Chitosan: Properties, preparation and application to microparticulate systems. Journal of Microencapsulation 1997; 14: 689–711
  • Krishnaiah YSR, Seetha DA, Nageswara RL, Bhaskar RPR, Karthikeyan RS, Satyanargana V. Guar gum as a carrier for colon specific delivery; influences of metronidazol and tinidazol on in vitro release of albendazol from guar gum matrix tablets. Journal of Pharmacy and Pharmaceutical Science 2001; 4: 235–243
  • Kweon DK, Kang DW. Drug release behavior of chitosan-gpoly (vinyl alcohol) copolymer matrix. Journal of Applied Polymer Science 1999; 74: 458–464
  • Lorenso-Lomasa ML, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Design of microencapsulated chitosan microspheres for colonic drug delivery. Journal of Controlled Release 1998; 52: 109–118
  • Luessen HL, de Leeuw BJ, Langemeyer MWE, de Boer AB, Verhoef JC, Junginger HE. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug Buserelin in vitro. Pharmaceutical Research 1996; 12: 1668–1672
  • Macfarlane GT, Cummings JH. The colonic flora, fermentation, and large bowel digestive function. The large intestine: Physiology, pathophysiology, and diseases, SF Phillips, JH Pemberton, RG Shoter. Raven Press, New York 1991; 51–92
  • Mathiowitz E, Chickering III D, Lehr C. Bioadhesive drug delivery systems, fundamentals, novel approaches, and development. Marcel Dekker, New York 1999; 100–480
  • Miyazaki Y, Ogihara K, Yakou S, Nagai T, Takayama K. In vitro and in vivo evaluation of mucoadhesive microspheres consisting of dextran derivatives and CAB. International Journal of Pharmaceutics 2003; 258: 21–29
  • Onishi H, Machida Y. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 1999; 20: 175–182
  • Peppercorn MA. The medical therapy of ulcerative colitis and Crohn's disease. Inflammatory bowel disease, RPM Dermot, WF Stevenson. Elsevier Science Publishing, New York 1992; 555–577
  • Pongpaibul Y, Wilworth CW. Preparation and in vitro dissolution characteristics of propranolol microcapsules. International Journal of Pharmaceutics 1986; 33: 243–248
  • Ramesh HP, Viswanatha S, Tharanathan RN. Safety evaluation of formulations containing carboxymethyl derivatives of starch and chitosan in albino rats. Carbohydrate Polymers 2004; 58: 435–441
  • Remunan-Lopez C, Lorenzo-Lamosa ML, Vila-Jato JL, Alonso MJ. Development of new chitosan-cellulose multicore microparticles for controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 1998; 45: 49–56
  • Rijk MCM, Schaik AV, Tongeren JHMV. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds. Scandinavian Journal of Gastroenterology 1988; 23: 107–112
  • Ruiz R, Sark A, Sprockel OL. A study on the manufacture and in vitro dissolution of terbutaline sulfate microcapsules. Drug Development and Industrial Pharmacy 1990; 16: 1829–1842
  • Shareef MA, Khar RK, Ahuja A, Ahmad FJ, Raghava S. Colonic drug delivery: An updated review. AAPS Pharmaceutical Science 2003; 5: 4
  • Sprockel OL, Prapaitrakul W. A comparison of microencapsulation by various emulsion techniques. International Journal of Pharmaceutics 1990; 58: 123–127
  • Tefft J, Friend DR. Controlled release of herbicide formulations based on polymeric microsphers. Journal of Controlled Release 1993; 27: 27–35
  • Vandamme ThF, Lenourry A, Charrueav C, Chaumeil JC. The use of polysaccharides to target drugs at the colon. Carbohyrate Polymers 2002; 48: 219–231
  • Vasir JK, Tambwelear K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. International Journal of Pharmaceutics 2003; 255: 13–32
  • Vos MD, Verdievel H, Schoonjans R, Praet M, Bogaert M, Barbier F. Concentrations of 5-ASA and Ac-5-ASA in human ileocolonic biopsy homogenates after oral 5-ASA preparations. Gut 1992; 33: 1338–1342
  • Wu CS. A comparison of the structure, thermal properties, and biodegradability of polycaprolactone/chitosan and acrylic acid grafted polycaprolactone/chitosan. Polymer 2005; 46: 147–155
  • Yamamoto A, Tozaki H, Okada N, Fujita T. Colon specific delivery of peptide drugs and anti-inflammatory drugs using chitosan capsules. S.T.P. Pharma Sciences 2000; 10: 23–43
  • Yang L, Chu JS, Fix JA. Colon-specific drug delivery, new approaches. An in-vivo, in-vitro evaluation. International Journal of Pharmaceutics 2002; 235: 1–15
  • Zahirul M, Khan I, Prebey E, Kurjakovi NA. PH-dependent colon polymers. Journal of Controlled Release 1999; 58: 215–222

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.